Archer’s FusionPlex Core Solid Tumor panel enables simultaneous detection of fusions, splice variants, key SNV/Indels, and relative RNA expression from the same input to drive cost efficiency. The panel features expanded SNV/Indel coverage over key genes, including tumor suppressors. With Anchored Multiplex PCR (AMP™) chemistry at the core and an integrated bioinformatic platform, FusionPlex targeted NGS assays offer streamlined RNA-based analysis from sample to data.
Solid Tumor
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), AXL (AXL Receptor Tyrosine Kinase), BRAF (B-raf proto-oncogene), BRD3 (Bromodomain Containing 3), BRD4 (Bromodomain Containing 4)
See More ...
Next-Generation Sequencing (NGS)